4-[3-(2-butyl-4-chloro-1H-imidazol-5-yl)-2-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-3,4-dihydropyrazol-5-yl]aniline

C25H24Cl2N6S — CID 44818253

IUPAC4-[3-(2-butyl-4-chloro-1H-imidazol-5-yl)-2-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-3,4-dihydropyrazol-5-yl]aniline
SMILESCCCCc1nc(Cl)c(C2CC(c3ccc(N)cc3)=NN2c2nc(-c3ccc(Cl)cc3)cs2)[nH]1
InChIInChI=1S/C25H24Cl2N6S/c1-2-3-4-22-30-23(24(27)31-22)21-13-19(15-7-11-18(28)12-8-15)32-33(21)25-29-20(14-34-25)16-5-9-17(26)10-6-16/h5-12,14,21H,2-4,13,28H2,1H3,(H,30,31)
InChIKeyCQNPJVINSHOTME-UHFFFAOYSA-N
MW511.48 g/mol
LogP7.12
Rot. Bonds7

About 4-[3-(2-butyl-4-chloro-1H-imidazol-5-yl)-2-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-3,4-dihydropyrazol-5-yl]aniline

4-[3-(2-butyl-4-chloro-1H-imidazol-5-yl)-2-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-3,4-dihydropyrazol-5-yl]aniline (PubChem CID 44818253) has the molecular formula C25H24Cl2N6S and a molecular weight of 511.48 g/mol. Its IUPAC name is 4-[3-(2-butyl-4-chloro-1H-imidazol-5-yl)-2-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-3,4-dihydropyrazol-5-yl]aniline.

Molecular Properties

Compound Name4-[3-(2-butyl-4-chloro-1H-imidazol-5-yl)-2-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-3,4-dihydropyrazol-5-yl]aniline
PubChem CID44818253
Molecular FormulaC25H24Cl2N6S
Molecular Weight511.48 g/mol
Exact Mass510.12
IUPAC Name4-[3-(2-butyl-4-chloro-1H-imidazol-5-yl)-2-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-3,4-dihydropyrazol-5-yl]aniline
SMILESCCCCc1nc(Cl)c(C2CC(c3ccc(N)cc3)=NN2c2nc(-c3ccc(Cl)cc3)cs2)[nH]1
InChIInChI=1S/C25H24Cl2N6S/c1-2-3-4-22-30-23(24(27)31-22)21-13-19(15-7-11-18(28)12-8-15)32-33(21)25-29-20(14-34-25)16-5-9-17(26)10-6-16/h5-12,14,21H,2-4,13,28H2,1H3,(H,30,31)
InChIKeyCQNPJVINSHOTME-UHFFFAOYSA-N
XLogP7.12
TPSA83.19 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds7
Heavy Atoms34
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500511.48
LogP ≤ 57.12
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aniline', 'substructure': 'N/A'}

Analyze 4-[3-(2-butyl-4-chloro-1H-imidazol-5-yl)-2-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-3,4-dihydropyrazol-5-yl]aniline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-[3-(2-butyl-4-chloro-1H-imidazol-5-yl)-2-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-3,4-dihydropyrazol-5-yl]aniline?
The IUPAC name of 4-[3-(2-butyl-4-chloro-1H-imidazol-5-yl)-2-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-3,4-dihydropyrazol-5-yl]aniline (CID 44818253) is 4-[3-(2-butyl-4-chloro-1H-imidazol-5-yl)-2-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-3,4-dihydropyrazol-5-yl]aniline.
What is the SMILES notation for 4-[3-(2-butyl-4-chloro-1H-imidazol-5-yl)-2-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-3,4-dihydropyrazol-5-yl]aniline?
The canonical SMILES for 4-[3-(2-butyl-4-chloro-1H-imidazol-5-yl)-2-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-3,4-dihydropyrazol-5-yl]aniline is CCCCc1nc(Cl)c(C2CC(c3ccc(N)cc3)=NN2c2nc(-c3ccc(Cl)cc3)cs2)[nH]1.
What is the InChIKey of 4-[3-(2-butyl-4-chloro-1H-imidazol-5-yl)-2-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-3,4-dihydropyrazol-5-yl]aniline?
The InChIKey is CQNPJVINSHOTME-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H24Cl2N6S/c1-2-3-4-22-30-23(24(27)31-22)21-13-19(15-7-11-18(28)12-8-15)32-33(21)25-29-20(14-34-25)16-5-9-17(26)10-6-16/h5-12,14,21H,2-4,13,28H2,1H3,(H,30,31).
What are the key properties of 4-[3-(2-butyl-4-chloro-1H-imidazol-5-yl)-2-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-3,4-dihydropyrazol-5-yl]aniline?
4-[3-(2-butyl-4-chloro-1H-imidazol-5-yl)-2-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-3,4-dihydropyrazol-5-yl]aniline has a molecular weight of 511.48 g/mol, XLogP of 7.12, 7 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[3-(2-butyl-4-chloro-1H-imidazol-5-yl)-2-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-3,4-dihydropyrazol-5-yl]aniline is sourced from PubChem (CID 44818253), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).